✦ LIBER ✦

Modern approaches to quality evaluation of generic drugs for their registration (a review)

✍ Scribed by G. V. Ramenskaya; I. E. Shokhin

Publisher: Springer
Year: 2009
Tongue: English
Weight: 78 KB
Volume: 43
Category: Article
ISSN: 0091-150X
DOI: 10.1007/s11094-009-0337-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A statistical approach to the generation

A statistical approach to the generation of a database for evaluating OCR software

✍ F.S. Brundick; Ann E.M. Brodeen; Malcolm S. Taylor 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 235 KB

A general approach to the evaluation of

A general approach to the evaluation of consistent tangent operators for rate-independent elastoplasticity

✍ G. Alfano; L. Rosati 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 1016 KB

We present a general approach to the derivation of the explicit expression of tangent operators, consistent with the finite-step integration schemes of the flow rule, for rate-independent elastoplastic models with mixed hardening. By exploiting the model of generalized standard material, we show tha

A new approach to evaluation of the resu

A new approach to evaluation of the results of drug testing for the pyrogenic effect according to the European Pharmacopoeia

✍ G. V. Dolgova; G. Ya. Kivman; A. S. Rykov; N. P. Neugodova; Z. N. Enikeeva 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 694 KB

General method for evaluating the fracti

General method for evaluating the fraction of the irreversible organ clearance due to conversion of drug to a primary metabolite

✍ W. F. Bayne; S. S. Hwang 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Utility of a physiologically–based pharm

Utility of a physiologically–based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug–drug–disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice

✍ Joseph A. Grillo; Ping Zhao; Julie Bullock; Brian P. Booth; Min Lu; Kathy Robie- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Background: Rivaroxaban is an oral Factor Xa inhibitor. The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment are co-administered with another drug that is both a P-gp and a moderate CYP3A4

Diagnostic DHPLC Quality Assurance (DDQA

Diagnostic DHPLC Quality Assurance (DDQA): A collaborative approach to the generation of validated and standardized methods for DHPLC-based mutation screening in clinical genetics laboratories

✍ Els Schollen; Elisabeth Dequeker; Shirley McQuaid; Bruno Vankeirsbilck; Genevièv 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

Genetic testing in a clinical diagnostic environment must be subject to rigorous quality control procedures, in order to ensure consistency and accuracy of results. Denaturing high performance liquid chromatography (DHPLC) has become a standard prescreening tool for mutation detection, offering very